Nepsone is a preclinical-stage pharmaceutical company developing drugs to treat dermatological conditions that arise due to an imbalance in the autonomic nervous system. Currently, these conditions are believed to originate in the immune system. Nepsone foundational neuroimmunology theory on the origin of psoriasis teaches us that an imbalance in neuropeptide activity in the body leads to these conditions. Our drugs are designed to utilize the body’s natural mechanisms to bring back balance and alleviate the disease.
Company Details
- Employees
- 6
- Founded
- -
- Address
- Reykjavik, Is
- Industry
- Pharmaceutical Manufacturing
- NAICS
-
Pharmaceutical and Medicine ManufacturingMedicinal and Botanical ManufacturingPharmaceutical Preparation ManufacturingIn-Vitro Diagnostic Substance ManufacturingBiological Product (except Diagnostic) Manufacturing
- Website
- https://nepsone.com
- HQ
- Reykjavik
Nepsone Ehf Questions
Nepsone Ehf's website is https://nepsone.com
Nepsone Ehf's LinkedIn profile is https://is.linkedin.com/company/nepsone
Nepsone Ehf has
6 employees.
View email and phone details for 6
employees at Nepsone Ehf.
Nepsone Ehf's industry is
Pharmaceutical Manufacturing
Nepsone Ehf's top competitors are
Akthelia Pharmaceuticals,
Distica,
Florealis,
Fjordholt Scientific,
Boehringer Ingelheim,
Ailsa Consulting,
Icemedico Ehf,
Pulmopharma Aps,
Zalvac Ab,
Day Zero Ehf..
Nepsone Ehf's categories are Pharmaceutical Manufacturing
Nepsone Ehf's founding year is 2004
